Glycine reuptake inhibitor

From WikiMD's Medical Encyclopedia

Revision as of 17:59, 8 March 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Glycine reuptake inhibitor (GRI) is a type of pharmaceutical drug that functions by inhibiting the glycine transporter. This action increases the concentration of glycine in the synaptic cleft, which can have various effects on neurological and psychiatric conditions.

Mechanism of Action

The primary function of a glycine reuptake inhibitor is to inhibit the action of the glycine transporter. This transporter is responsible for the reuptake of glycine from the synaptic cleft back into the neuron. By inhibiting this process, GRIs increase the concentration of glycine in the synaptic cleft.

Glycine is an important neurotransmitter in the central nervous system, where it serves as an inhibitory neurotransmitter in the spinal cord and brainstem, and a co-agonist along with glutamate at the NMDA receptor. By increasing the availability of glycine, GRIs can enhance NMDA receptor function.

Clinical Uses

Glycine reuptake inhibitors have potential therapeutic applications in a variety of neurological and psychiatric conditions. These include schizophrenia, obsessive-compulsive disorder (OCD), and certain types of neuropathic pain.

In schizophrenia, GRIs may help to alleviate negative symptoms and cognitive deficits, which are not effectively treated by current antipsychotic medications. In OCD, GRIs may reduce symptoms by enhancing NMDA receptor function. In neuropathic pain, GRIs may work by reducing hyperexcitability in the spinal cord.

Side Effects

As with any medication, glycine reuptake inhibitors can have side effects. These may include nausea, vomiting, diarrhea, and dizziness. More serious side effects can include seizures and hallucinations. It is important for patients to discuss potential side effects with their healthcare provider before starting treatment with a GRI.

See Also

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.